As of 2:31 PM on the 2nd, Humasis is trading at 8,330 KRW, the same price as the previous day. This represents a 45.91% decline compared to June 24. Humasis is known as an in vitro diagnostic device company.
Over the past five days, individual investors have net purchased 440,937 shares, while foreign investors and institutions have net sold 105,619 shares and 213,533 shares, respectively.
On June 25, Humasis became a market issue with the headline "Plunged to the lower limit after 6 consecutive gains."

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
